Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists

Yu Juan Zhang, Liu Lan Shen, Hyae Gyeong Cheon, Yong Nan Xu, Jin-Hyun Jeong

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

In this study, a series of fused-heterocyclic derivatives were systematically designed and synthesized using an efficient route, and evaluated in terms of GLP-1R agonist activity. We employed short synthetic steps and reactions that are tolerant of the presence of various functional groups and suitable for parallel operations to enable the rapid generation of libraries of diverse and structurally complex small molecules. Of the compounds synthesized, 3-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a] pyridin-2-yl)phenyl methanesulfonate (8e) was the most potent agonist with an EC50 of 7.89 μM, and thus is the compound with the greatest potential for application. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1R agonists that can be administered orally.

Original languageEnglish
Pages (from-to)588-599
Number of pages12
JournalArchives of pharmacal research
Volume37
Issue number5
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Libraries
Molecules
Functional groups
Derivatives
Glucagon-Like Peptide-1 Receptor
methanesulfonic acid

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery
  • Organic Chemistry

Cite this

Zhang, Yu Juan ; Shen, Liu Lan ; Cheon, Hyae Gyeong ; Xu, Yong Nan ; Jeong, Jin-Hyun. / Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists. In: Archives of pharmacal research. 2014 ; Vol. 37, No. 5. pp. 588-599.
@article{f6c3be4892384aa09c516b62d9f67790,
title = "Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists",
abstract = "In this study, a series of fused-heterocyclic derivatives were systematically designed and synthesized using an efficient route, and evaluated in terms of GLP-1R agonist activity. We employed short synthetic steps and reactions that are tolerant of the presence of various functional groups and suitable for parallel operations to enable the rapid generation of libraries of diverse and structurally complex small molecules. Of the compounds synthesized, 3-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a] pyridin-2-yl)phenyl methanesulfonate (8e) was the most potent agonist with an EC50 of 7.89 μM, and thus is the compound with the greatest potential for application. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1R agonists that can be administered orally.",
author = "Zhang, {Yu Juan} and Shen, {Liu Lan} and Cheon, {Hyae Gyeong} and Xu, {Yong Nan} and Jin-Hyun Jeong",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/s12272-013-0253-9",
language = "English",
volume = "37",
pages = "588--599",
journal = "Archives of Pharmacal Research",
issn = "0253-6269",
publisher = "Pharmaceutical Society of Korea",
number = "5",

}

Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists. / Zhang, Yu Juan; Shen, Liu Lan; Cheon, Hyae Gyeong; Xu, Yong Nan; Jeong, Jin-Hyun.

In: Archives of pharmacal research, Vol. 37, No. 5, 01.01.2014, p. 588-599.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthesis and biological evaluation of glucagon-like peptide-1 receptor agonists

AU - Zhang, Yu Juan

AU - Shen, Liu Lan

AU - Cheon, Hyae Gyeong

AU - Xu, Yong Nan

AU - Jeong, Jin-Hyun

PY - 2014/1/1

Y1 - 2014/1/1

N2 - In this study, a series of fused-heterocyclic derivatives were systematically designed and synthesized using an efficient route, and evaluated in terms of GLP-1R agonist activity. We employed short synthetic steps and reactions that are tolerant of the presence of various functional groups and suitable for parallel operations to enable the rapid generation of libraries of diverse and structurally complex small molecules. Of the compounds synthesized, 3-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a] pyridin-2-yl)phenyl methanesulfonate (8e) was the most potent agonist with an EC50 of 7.89 μM, and thus is the compound with the greatest potential for application. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1R agonists that can be administered orally.

AB - In this study, a series of fused-heterocyclic derivatives were systematically designed and synthesized using an efficient route, and evaluated in terms of GLP-1R agonist activity. We employed short synthetic steps and reactions that are tolerant of the presence of various functional groups and suitable for parallel operations to enable the rapid generation of libraries of diverse and structurally complex small molecules. Of the compounds synthesized, 3-(8-chloro-6-(trifluoromethyl)imidazo[1,2-a] pyridin-2-yl)phenyl methanesulfonate (8e) was the most potent agonist with an EC50 of 7.89 μM, and thus is the compound with the greatest potential for application. These findings represent a valuable starting point for the design and discovery of small-molecule GLP-1R agonists that can be administered orally.

UR - http://www.scopus.com/inward/record.url?scp=84901267961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901267961&partnerID=8YFLogxK

U2 - 10.1007/s12272-013-0253-9

DO - 10.1007/s12272-013-0253-9

M3 - Article

VL - 37

SP - 588

EP - 599

JO - Archives of Pharmacal Research

JF - Archives of Pharmacal Research

SN - 0253-6269

IS - 5

ER -